Brief: Viracta Therapeutics Reports First Quarter 2021 Financial Results And Provides Clinical And Corporate Updates
May 12 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CLINICAL AND CORPORATE UPDATES
* Q1 LOSS PER SHARE $5.22
* Q1 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
* VIRACTA THERAPEUTICS - CASH, EQUIVALENTS OF ABOUT $129.2
MILLION
AS OF MARCH 31, 2021
* VIRACTA THERAPEUTICS - EXPECTS TO END 2021 WITH GREATER
THAN
$100 MILLION IN CASH, EQUIVALENTS
Source text for Eikon: ID:nPnbncvzya
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update